Bigul

INDOCO REMEDIES LTD. - 532612 - Intimation To Shareholders Holding Shares In Physical Mode Regarding Mandatory Furnishing Of PAN, KYC, Nomination And Bank Details As Per SEBI Circular Dated 16Th March, 2023

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed herewith a copy of the letter along with necessary forms dispatched to the shareholders holding shares in physical mode, in compliance with the SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated 16th March, 2023.
30-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Pursuant to Regulation 24A(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Annual Secretarial Compliance Report dated 25th May, 2023 for the Financial Year 2022-23 issued by our secretarial auditor CS Ajit Sathe, Proprietor of M/s. A. Y. Sathe & Co., Company Secretaries. We request you to kindly take the above in your records.
27-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Newspaper advertisement confirming dispatch of the Postal Ballot Notice published on 27th May, 2023 in Business Standard (English) (All Editions), and Mumbai Lakshdeep (Marathi). We request you to kindly take the above in your records.
27-05-2023

Buy Indoco Remedies; target of Rs 400: Prabhudas Lilladher

Prabhudas Lilladher is bullish on Indoco Remedies has recommended buy rating on the stock with a target price of Rs 400 in its research report dated May 24, 2023.
26-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed the transcript of Earnings Conference Call held on 23rd May, 2023 in respect of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2023.
26-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed copy of the postal ballot notice dated 23rd May, 2023 ('Postal Ballot Notice') to seek approval of the shareholders for re-appointment of Mr. Suresh G. Kare as Chairman of the Company in the capacity of Non-Executive Non Independent Director and to advance any loan, give any guarantee or to provide any security to all such person specified under section 185 of the Companies Act, 2013.
26-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31st March, 2023
24-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

In compliance with Regulation 8 (2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, it is to inform that the Board of Directors of the Company in their meeting held on 23rd May, 2023 has adopted the revised 'Code of Conduct for Prevention of Insider Trading and Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information' (Insider Trading Code). The revised Insider Trading Code is enclosed herewith
23-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Disclosure Of Related Party Transactions Pursuant To Regulation 23(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015

Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions for the half year ended 31st March, 2023. This is for your information and records.
23-05-2023
Bigul

INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Audio recording of earnings conference call for the quarter and year ended 31st March 2023
23-05-2023
Next Page
Close

Let's Open Free Demat Account